Skip to content
Clinical Trials – home
SlovakiaBack to Slovakia

Clinical trials in Nove Mesto – page 3

368 clinical trials in Nove Mesto, Slovakia across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SlovakiaOur site in SlovakiaKlinickeSkusky.sk(opens in a new tab)
Nove Mesto at a glance
368
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

368 trials in Nove Mesto

Open in trial search

Study of vicadrostat and empagliflozin combination in patients with type 2 diabetes, high blood pressure and cardiovascular disease

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim Espana S.A.

Study of laroprovstat (AZD0780) to reduce heart attack, stroke and vascular complications in patients with atherosclerotic cardiovascular disease or high risk of developing it

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Laroprovstat
  • Sponsor:AstraZeneca AB

Crohn's disease

Recruiting

Study of tulisokibart compared to placebo in adults with moderate to severe Crohn's disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tulisokibart
  • Sponsor:Merck Sharp & Dohme LLC

Cardiac failure

Recruiting

Evaluating the Effect of Vicadrostat and Empagliflozin Combination Compared to Empagliflozin Alone in Patients with Heart Failure and Reduced Left Ventricular Function

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:BI 690517
  • Sponsor:Boehringer Ingelheim International GmbH

Study on ITI-1284 for Patients with Generalized Anxiety Disorder Who Did Not Respond Well to Previous Treatments

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:ITI-1284
  • Sponsor:Intra-Cellular Therapies Inc.

Colitis ulcerative+1

Recruiting

Study on Long-term Safety of Zasocitinib for Adults with Moderate to Severe Ulcerative Colitis and Crohn's Disease

InvestigationalNo placebo
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Zasocitinib
  • Sponsor:Takeda Development Center Americas Inc.

Crohn's disease

Recruiting

Study of RO7790121 (afimkibart) for Treatment and Long-term Management in Adults with Moderate to Severe Crohn's Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of RO7790121 for Patients with Moderate to Severe Crohn's Disease

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:RO7790121
  • Sponsor:F. Hoffmann-La Roche AG

Study on the Effects of Baxdrostat and Dapagliflozin in Adults with Chronic Kidney Disease and High Blood Pressure

Registered drug
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Baxdrostat
  • Sponsor:AstraZeneca AB

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Tozorakimab
  • Sponsor:AstraZeneca AB

Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

Investigational
Countries:SlovakiaSlovakia
  • Participants:18–64 years · 65+ years
  • Substances:Selatogrel
  • Sponsor:Viatris Innovation GmbH

Other cities in Slovakia

The busiest research cities in the country

All 88 cities in Slovakia

Clinical research in Nove Mesto

What the registry says about research in the country

01 Cardiovascular Diseases

Clinical trial activity in Nove Mesto includes research in cardiovascular diseases, with a focus on atrial fibrillation and stable angina pectoris. These studies are designed to assess new treatment options and confirm whether emerging therapies can better prevent complications or relieve symptoms.

  • Prevention of cardioembolic events in atrial fibrillation
  • Evaluation of anti-anginal effects in stable angina pectoris
  • Testing treatment effectiveness for ongoing heart-related conditions

Overall, this area reflects active work aimed at improving both protection from serious cardiovascular events and day-to-day symptom control.

02 Digestive System and Liver Disorders

Another important research focus is digestive system diseases, especially studies involving hepatic impairment and moderate or severe hepatic impairment. These trials look at how liver problems may affect the safety and behavior of investigational therapies, helping define whether treatments can be used more effectively in people with liver disease.

  • Study of liver-related effects on treatment use
  • Research involving hepatic impairment and liver problems
  • Assessment of safety and tolerability in patients with compromised liver function

This area supports safer prescribing decisions and better understanding of how new therapies perform in patients with liver conditions.

03 Nutritional and Metabolic Diseases

Trials in nutritional and metabolic diseases are centered on hypertriglyceridemia and severe hypertriglyceridemia, reflecting a clear effort to improve management of abnormal lipid levels. The research is mainly aimed at testing whether new therapies can lower triglycerides and support better metabolic health.

  • Reduction of fasting serum triglyceride levels
  • Studies in hypertriglyceridemia and severe hypertriglyceridemia
  • Evaluation of treatment effectiveness for lipid-related disorders

These studies are relevant for patients at risk of complications linked to elevated triglycerides and broader metabolic imbalance.

04 Unspecified Therapeutic Area

Some studies in the city span broader or not fully specified categories, but they still contribute to a diverse clinical research environment. The overall pattern suggests work across multiple medical fields, with a strong emphasis on evaluating new therapies, confirming benefits, and improving how existing conditions are managed.

  • Broad clinical research across multiple disease areas
  • Testing the value of emerging treatment approaches
  • Supporting better disease management through clinical evaluation

With several recruiting sites active, the local trial landscape in Slovakia remains focused on practical questions that matter for patient care.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.